NATALIE PRAGOVICH: Open Payments
NPI 1295478949 · ROLLING MEADOWS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 27 payments from 18 companies in 2025. Trend: 2023 $60 · 2024 $28 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $141 |
| E.R. Squibb & Sons, L.L.C. | 2 | $61 |
| Incyte Corporation | 2 | $57 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| BeOne Medicines USA, Inc. | 2 | $55 |
| Celgene Corporation | 2 | $53 |
| Aveo Pharmaceuticals, Inc. | 1 | $38 |
| Nuvation Bio Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: JAKAFI, LUTATHERA, KEYTRUDA, KISQALI, BRUKINSA, REBLOZYL, FOTIVDA, IBTROZI.
Industry payments across IL — which companies pay providers there.
